Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panos Savvides

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Seminars in Plastic Surgery|May 3, 2012
The role of chemotherapy in the management of patients with head and neck cancerPanayiotis Panos Savvides
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 15, 2005
Canalith repositioning for benign paroxysmal positional vertigoJudith White, Panos Savvides, Neil Cherian, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 30, 2003
Development and validation of a patient-specific predictive instrument for the need for dose reduction in chemotherapy for breast cancer: a potential decision aid for the use of myeloid growth factorsPanos Savvides, Norma Terrin, John Erban, et al.
Head & Neck|June 24, 2014
Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neckMin Yao, Nicholas Galanopoulos, Pierre Lavertu, et al.
Transactions of the American Clinical and Climatological Association|June 6, 2008
Cancer in the elderlyNathan A Berger, Panos Savvides, Siran M Koroukian, et al.
Investigational New Drugs|June 20, 2020
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumorsJennifer R Eads, Smitha S Krishnamurthi, Joel Saltzman, et al.
Clinical Lung Cancer|October 25, 2023
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung CancerAakash Desai, Caleb J Smith, Yash Ashara, et al.
Cancer Treatment and Research Communications|August 2, 2023
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief reportAakash Desai, Sagar Rakshit, Radhika Bansal, et al.
Oral Oncology|March 31, 2018
Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinomaChristian L Barney, Steve Walston, Pedro Zamora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell CarcinomaElizabeth L McMichael, Brooke Benner, Lakhvir S Atwal, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Seminars in Plastic Surgery|May 3, 2012
The role of chemotherapy in the management of patients with head and neck cancerPanayiotis Panos Savvides
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 15, 2005
Canalith repositioning for benign paroxysmal positional vertigoJudith White, Panos Savvides, Neil Cherian, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 30, 2003
Development and validation of a patient-specific predictive instrument for the need for dose reduction in chemotherapy for breast cancer: a potential decision aid for the use of myeloid growth factorsPanos Savvides, Norma Terrin, John Erban, et al.
Head & Neck|June 24, 2014
Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neckMin Yao, Nicholas Galanopoulos, Pierre Lavertu, et al.
Transactions of the American Clinical and Climatological Association|June 6, 2008
Cancer in the elderlyNathan A Berger, Panos Savvides, Siran M Koroukian, et al.
Investigational New Drugs|June 20, 2020
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumorsJennifer R Eads, Smitha S Krishnamurthi, Joel Saltzman, et al.
Clinical Lung Cancer|October 25, 2023
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung CancerAakash Desai, Caleb J Smith, Yash Ashara, et al.
Cancer Treatment and Research Communications|August 2, 2023
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief reportAakash Desai, Sagar Rakshit, Radhika Bansal, et al.
Oral Oncology|March 31, 2018
Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinomaChristian L Barney, Steve Walston, Pedro Zamora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell CarcinomaElizabeth L McMichael, Brooke Benner, Lakhvir S Atwal, et al.
Pageof 1